Theravance Biopharma, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2014 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Theravance Biopharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2014 to Q3 2024.
  • Theravance Biopharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 49.2M shares, a 1.25% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 49.2M -624K -1.25% Nov 8, 2024 10-Q 2024-11-14
Q2 2024 48.9M -3.89M -7.37% Aug 2, 2024 10-Q 2024-08-08
Q1 2024 48.6M -9.16M -15.9% May 3, 2024 10-Q 2024-05-15
Q3 2023 49.8M -17.6M -26.1% Nov 1, 2023 10-Q 2023-11-09
Q2 2023 52.8M -23.6M -30.9% Aug 1, 2023 10-Q 2023-08-09
Q1 2023 57.8M -18.3M -24.1% May 1, 2023 10-Q/A 2023-05-18
Q3 2022 67.4M -6.33M -8.59% Oct 31, 2022 10-Q 2022-11-09
Q2 2022 76.4M +2.96M +4.03% Aug 1, 2022 10-Q 2022-08-08
Q1 2022 76.1M +10.8M +16.6% Apr 29, 2022 10-Q 2022-05-06
Q3 2021 73.7M +9.72M +15.2% Oct 29, 2021 10-Q 2021-11-08
Q2 2021 73.5M +9.95M +15.7% Jul 30, 2021 10-Q 2021-08-05
Q1 2021 65.3M +2.19M +3.47% Apr 30, 2021 10-Q 2021-05-06
Q3 2020 64M +7.22M +12.7% Oct 30, 2020 10-Q 2020-11-09
Q2 2020 63.5M +6.88M +12.1% Jul 31, 2020 10-Q 2020-08-10
Q1 2020 63.1M +6.95M +12.4% Apr 30, 2020 10-Q 2020-05-08
Q3 2019 56.8M +1.35M +2.44% Oct 25, 2019 10-Q 2019-11-08
Q2 2019 56.6M +1.53M +2.78% Jul 26, 2019 10-Q 2019-08-05
Q1 2019 56.1M +1.28M +2.34% Apr 30, 2019 10-Q 2019-05-10
Q3 2018 55.4M +1.31M +2.42% Oct 31, 2018 10-Q 2018-11-08
Q2 2018 55.1M +1.27M +2.37% Jul 31, 2018 10-Q 2018-08-02
Q1 2018 54.9M +1.49M +2.8% May 1, 2018 10-Q 2018-05-09
Q4 2017 54.4M +1.53M +2.89% Jan 31, 2018 10-K 2018-02-28
Q3 2017 54.1M +2.16M +4.16% Nov 1, 2017 10-Q 2017-11-08
Q2 2017 53.8M +5.98M +12.5% Aug 1, 2017 10-Q 2017-08-09
Q1 2017 53.4M +14.9M +38.8% May 1, 2017 10-Q 2017-05-10
Q4 2016 52.9M Jan 31, 2017 10-K 2017-03-01
Q3 2016 51.9M +14.1M +37.3% Nov 3, 2016 10-Q 2016-11-09
Q2 2016 47.9M +13.9M +41% Aug 1, 2016 10-Q 2016-08-09
Q1 2016 38.4M +4.63M +13.7% Feb 29, 2016 10-K 2016-03-11
Q3 2015 37.8M +5.61M +17.4% Oct 31, 2015 10-Q 2015-11-12
Q2 2015 33.9M +1.68M +5.2% Jul 31, 2015 10-Q 2015-08-13
Q1 2015 33.8M Apr 30, 2015 10-Q 2015-05-13
Q3 2014 32.2M Oct 31, 2014 10-Q 2014-11-12
Q2 2014 32.3M Jun 6, 2014 10-Q 2014-06-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.